Home
LiteratureArticle Details
PMID: 17526090
Published · ppublish
English
Letter
Comment
Posaconazole prophylaxis in hematologic cancer.
The New England journal of medicine
·Vol. 356
·No. 21
·2007-05-24
·Pages 2214-5; author reply 2215-8
Abstract
暂无摘要
MeSH Terms
Antifungal Agents/therapeutic use
Aspergillosis/drug therapy
Aspergillus/drug effects,genetics
Cytochrome P-450 Enzyme System/genetics
Drug Resistance, Fungal/genetics
Humans
Mucositis
Mycoses/prevention & control
Opportunistic Infections/prevention & control
Oxidoreductases/genetics
Point Mutation
Pyrimidines/therapeutic use
Sterol 14-Demethylase
Triazoles/therapeutic use
Voriconazole
Chemicals
Antifungal Agents
CYP51A1 protein, human
Pyrimidines
Triazoles
posaconazole
Cytochrome P-450 Enzyme System
Oxidoreductases
Sterol 14-Demethylase
Voriconazole
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2007-05-24
Pages
2214-5; author reply 2215-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
